Palliative Care, Health ServicesPCDNCT07313748
Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.
An observational study of Palliative Care, Health Services, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 2 sites in Italy.
Trial summary
The goal of this observational, point-prevalence study is to assess the burden of palliative care needs among adults hospitalised in Internal Medicine and Geriatrics wards, and among residents of long-term care facilities, on the National Palliative Care Day (11 November). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Palliative Care, Health Services
- How many people
- 3,000 participants
- Where
- 2 sitesItaly
- Study dates
- 1 Nov 2025to 30 Jun 2026
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The study population consists of adults (≥18 years) hospitalised in Internal Medicine and Geriatrics wards, as well as residents of participating long-term care facilities for older adults (RSA Medicalizzata, R2, R2D, R3) on 11 November, the National Palliative Care Day. Participants represent a heterogeneous group of medically complex individuals, typically characterised by multimorbidity, functional impairment, advanced age, and a high burden of chronic disease. All eligible patients and residents present on the day of assessment will be considered for inclusion, provided informed consent can be obtained directly or with the support of a caregiver or legal proxy.
Who may be able to join
- Age ≥ 18 years
- Admitted to participating Internal Medicine or Geriatrics wards or resident in participating long-term care facilities for older adults (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November (National Palliative Care Day)
- Able to provide: written informed consent for study participation and data processing, or oral consent supported by a relative/caregiver/legal proxy
Who cannot join
- Inability to provide written informed consent and absence of a relative/caregiver/legal proxy able to support oral consent for participation and data processing
Trial locations and contacts
2 sites in 1 country.
Italy2 sites
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Rome, 00168
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, 00168
About this study
Official title: Palliative Care Day: Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.
The goal of this observational, point-prevalence study is to assess the burden of palliative care needs among adults hospitalised in Internal Medicine and Geriatrics wards, and among residents of long-term care facilities, on the National Palliative Care Day (11 November). The main question it aims to answer is: What is the prevalence of unmet palliative care needs in hospital and long-term care settings on 11 November? Participants (patients and residents) will be evaluated through a structured, web-based questionnaire designed for this study. The survey will collect clinical, functional, and symptom-related data- including comorbidities, mobility, nutritional status, dysphagia, pressure ulcers, indicators of palliative care needs (NECPAL), pain assessment, and delirium screening (4AT)-to produce a detailed snapshot of palliative care needs across settings.
Read the detailed description
The National Palliative Care Day, held annually on 11 November, provides a unique opportunity to assess the prevalence of palliative care needs among patients in hospitals and residents of long-term care facilities. Beyond raising awareness of palliative care, this occasion supports more accurate monitoring of patients with unmet palliative needs and enables the collection of concrete data on current care provision.
This study aims to measure the prevalence of palliative care needs among adults admitted to Internal Medicine and Geriatrics wards and among residents of participating long-term care facilities on 11 November. Assessment will be performed using a purpose-designed questionnaire. The study intends to: (1) generate a detailed estimate of palliative care needs in hospital and residential settings; (2) increase awareness among healthcare professionals and promote timely identification and management of palliative care needs; and (3) highlight the relevance of a palliative approach not only in traditional palliative care services (hospice, home-based palliative care) but also within hospitals and long-term care facilities.
A point-prevalence (cross-sectional) design will be used through administration of a web-based survey.
Sample
Inclusion criteria
Participants must meet all of the following:
- age ≥18 years;
- hospitalised in participating wards or residing in participating long-term care facilities (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November;
- able to provide written informed consent and consent for data processing, or oral consent supported by a relative, caregiver, or proxy.
Exclusion criteria Participants will be excluded if they are unable to provide written consent or supported oral consent for participation and data processing.
Questionnaire
Palliative care needs will be assessed using a dedicated questionnaire (Appendix 1), delivered via a web platform. The instrument comprises three sections:
Facility-level data:
- region;
- ward type (Internal Medicine, Geriatrics) or care model for long-term facilities;
- number of beds and number of eligible patients;
- availability of an in-house palliative care service (hospitals) or access to specialist palliative consultation (long-term care).
Rater characteristics:
- socio-demographic data (age group, sex);
- profession, years of experience, current or completed specialty training.
Patient-level data:
- socio-demographic variables (age, sex);
- comorbidities (Charlson Comorbidity Index);
- mobility (baseline and current functional status);
- daily nutritional intake and recent decline;
- dysphagia (presence and type);
- pressure ulcers (including stage III-IV lesions);
- palliative care indicators (NECPAL);
- pain assessment (Numeric Pain Rating Scale, or PAINAD for advanced dementia);
- delirium screening (4AT).
- Conditions
- Palliative Care, Health Services
- Keywords
- PALLIATIVE CARE, unmet needs, HOSPITAL, LONG-TERM RESIDENCE
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence
Prevalence of palliative care needs
Measured: 1 DAY
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jan 2026
- Study start1 Nov 2025
- Primary completion11 Nov 2025
- Study completion30 Jun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Palliative Care, Health ServicesStudies of the same condition, open and under way.
- More trials run by Fondazione Policlinico Universitario Agostino Gemelli IRCCSThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 3,000 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Graziano Onder, Principal investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07313748
- Sponsor's protocol ID
- 8190
- Acronym
- PCD
- Status last verified
- Nov 2025
- First submitted
- 21 Nov 2025
- Last updated
- 2 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Palliative Care Day: Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.
- ClinicalTrials.gov ID
- NCT07313748
- Acronym / sponsor ID
- PCD / 8190
- Conditions
- Palliative Care, Health Services
- Keywords
- PALLIATIVE CARE, unmet needs, HOSPITAL, LONG-TERM RESIDENCE
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 3,000 participants (estimated)
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSUniversity, hospital or other
- Study start
- 1 Nov 2025 (actual)
- Primary completion
- 11 Nov 2025 (actual)
- Study completion
- 30 Jun 2026 (estimated)
- First posted
- 2 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational, point-prevalence study is to assess the burden of palliative care needs among adults hospitalised in Internal Medicine and Geriatrics wards, and among residents of long-term care facilities, on the National Palliative Care Day (11 November). The main question it aims to answer is: What is the prevalence of unmet palliative care needs in hospital and long-term care settings on 11 November? Participants (patients and residents) will be evaluated through a structured, web-based questionnaire designed for this study. The survey will collect clinical, functional, and symptom-related data- including comorbidities, mobility, nutritional status, dysphagia, pressure ulcers, indicators of palliative care needs (NECPAL), pain assessment, and delirium screening (4AT)-to produce a detailed snapshot of palliative care needs across settings.
Detailed description
The National Palliative Care Day, held annually on 11 November, provides a unique opportunity to assess the prevalence of palliative care needs among patients in hospitals and residents of long-term care facilities. Beyond raising awareness of palliative care, this occasion supports more accurate monitoring of patients with unmet palliative needs and enables the collection of concrete data on current care provision.
This study aims to measure the prevalence of palliative care needs among adults admitted to Internal Medicine and Geriatrics wards and among residents of participating long-term care facilities on 11 November. Assessment will be performed using a purpose-designed questionnaire. The study intends to: (1) generate a detailed estimate of palliative care needs in hospital and residential settings; (2) increase awareness among healthcare professionals and promote timely identification and management of palliative care needs; and (3) highlight the relevance of a palliative approach not only in traditional palliative care services (hospice, home-based palliative care) but also within hospitals and long-term care facilities.
A point-prevalence (cross-sectional) design will be used through administration of a web-based survey.
Sample
Inclusion criteria
Participants must meet all of the following:
- age ≥18 years;
- hospitalised in participating wards or residing in participating long-term care facilities (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November;
- able to provide written informed consent and consent for data processing, or oral consent supported by a relative, caregiver, or proxy.
Exclusion criteria Participants will be excluded if they are unable to provide written consent or supported oral consent for participation and data processing.
Questionnaire
Palliative care needs will be assessed using a dedicated questionnaire (Appendix 1), delivered via a web platform. The instrument comprises three sections:
Facility-level data:
- region;
- ward type (Internal Medicine, Geriatrics) or care model for long-term facilities;
- number of beds and number of eligible patients;
- availability of an in-house palliative care service (hospitals) or access to specialist palliative consultation (long-term care).
Rater characteristics:
- socio-demographic data (age group, sex);
- profession, years of experience, current or completed specialty training.
Patient-level data:
- socio-demographic variables (age, sex);
- comorbidities (Charlson Comorbidity Index);
- mobility (baseline and current functional status);
- daily nutritional intake and recent decline;
- dysphagia (presence and type);
- pressure ulcers (including stage III-IV lesions);
- palliative care indicators (NECPAL);
- pain assessment (Numeric Pain Rating Scale, or PAINAD for advanced dementia);
- delirium screening (4AT).
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of adults (≥18 years) hospitalised in Internal Medicine and Geriatrics wards, as well as residents of participating long-term care facilities for older adults (RSA Medicalizzata, R2, R2D, R3) on 11 November, the National Palliative Care Day. Participants represent a heterogeneous group of medically complex individuals, typically characterised by multimorbidity, functional impairment, advanced age, and a high burden of chronic disease. All eligible patients and residents present on the day of assessment will be considered for inclusion, provided informed consent can be obtained directly or with the support of a caregiver or legal proxy.
Key inclusion criteria (3 listed)
- Age ≥ 18 years
- Admitted to participating Internal Medicine or Geriatrics wards or resident in participating long-term care facilities for older adults (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November (National Palliative Care Day)
- Able to provide: written informed consent for study participation and data processing, or oral consent supported by a relative/caregiver/legal proxy
Key exclusion criteria (1 listed)
- Inability to provide written informed consent and absence of a relative/caregiver/legal proxy able to support oral consent for participation and data processing
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence
Time frame: 1 DAY
Prevalence of palliative care needs
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jan 2026.
Related trials for Palliative Care, Health Services
Not yet recruiting
Integrating Rhythmical Massage in Palliative Care
Palliative Care, Health Services, Palliative Care
Recruiting
Nurse-led Integrated Home Service to Support Parents in Symptom Management for Children Requiring Respiratory Support
Children With Medical Complexity (CMC), Symptom Management
RecruitingObservational study
Breast Cancer Registry Platform
Breast Cancer
Recruiting
Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)
Cancer
Enrolling by invitationObservational study
Perceptions of Key Domains of Home-Based Palliative Care Among Healthcare Professionals (MULTIPAL)
Home Care, Hospital-Based, Palliative Care
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Graziano Onder principal investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Palliative Care, Health Services, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 2 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence (time frame: 1 DAY). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.